XML 83 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Other Real Estate Property Investments
12 Months Ended
Dec. 31, 2011
Other Real Estate Property Investments  
Other Real Estate Property Investments

(4) Other Real Estate Property Investments

        A summary of acquisitions for the year ended December 31, 2011 follows (in thousands):

 
  Consideration   Assets Acquired  
Acquisitions
  Cash Paid   Debt
Assumed
  Noncontrolling
Interest
  Real Estate   Net
Intangibles
 

Life science

  $ 84,087   $ 57,869   $   $ 133,210   $ 8,746  

Medical office

    29,743         1,500     26,191     5,052  
                       

 

  $ 113,830   $ 57,869   $ 1,500   $ 159,401   $ 13,798  
                       

        During the year ended December 31, 2011, the Company funded an aggregate of $127 million for construction, tenant and other capital improvement projects, primarily in the life science and medical office segments. During the year ended December 31, 2011, two of the Company's life science facilities located in South San Francisco were placed in service representing 88,000 square feet.

        A summary of acquisitions for the year ended December 31, 2010 follows (in thousands):

 
  Consideration   Assets Acquired  
Acquisitions
  Cash Paid   Debt
Assumed
  DownREIT
Units
  Other
Noncontrolling
Interest
  Real Estate   Net
Intangibles
 

Senior housing

  $ 143,926   $   $   $   $ 141,500   $ 2,426  

Life science

    40,563         7,341     190     43,017     5,077  

Medical office

    27,463     33,503 (1)   1,926     735     57,390     6,237  
                           

 

  $ 211,952   $ 33,503   $ 9,267   $ 925   $ 241,907   $ 13,740  
                           

(1)
Debt assumed includes a related interest-rate swap liability with a fair value of $3.2 million, at acquisition.

        During the year ended December 31, 2010, the Company funded an aggregate of $135 million for construction, tenant and other capital improvement projects, primarily in the life science and medical office segments. During the year ended December 31, 2010, three of the Company's life science facilities located in South San Francisco were placed into service representing 329,000 square feet.